NKTR Nektar Therapeutics

NASDAQ

$41.17

Nektar Therapeutics (NKTR) Earnings News

Earnings press releases, previews and reviews for Nektar Therapeutics (NKTR), newest first.

Thursday August 13, 2026 4:15 PM ET

Nektar Therapeutics Announces Second Quarter 2026 Financial Results

Tuesday July 28, 2026 6:00 PM ET

Nektar Therapeutics to Announce Financial Results for the Second Quarter on Thursday, August 13, 2026, After Close of U.S.-Based Financial Markets

Thursday May 7, 2026 4:15 PM ET

Nektar Therapeutics Reports First Quarter 2026 Financial Results

Tuesday April 28, 2026 6:00 PM ET

Nektar to Announce Financial Results for the First Quarter on Thursday, May 7, 2026, After Close of U.S.-Based Financial Markets

Sunday April 19, 2026 12:00 PM ET

Nektar to Hold Conference Call to Discuss 52-Week Topline Results from the 16-Week Extension Treatment Period for its REZOLVE-AA Phase 2b Study of Rezpegaldesleukin in Alopecia Areata on April 20, 2026